| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 02/19/1998 | WO1998006734A1 Novel prokaryotic polynucleotides, polypeptides and their uses |
| 02/19/1998 | WO1998006722A1 Thienopyrimidines |
| 02/19/1998 | WO1998006711A1 Butyric acid matrix metalloproteinase inhibitors |
| 02/19/1998 | WO1998006707A1 Cyclic carbamates and isoxazolidines as iib/iiia antagonists |
| 02/19/1998 | WO1998006705A1 Substituted pyrimidine derivatives and their pharmaceutical use |
| 02/19/1998 | WO1998006703A1 2-phenyl benzimidazole derivatives as mcp-1 antagonists |
| 02/19/1998 | WO1998006437A2 Compositions and methods for polynucleotide delivery |
| 02/19/1998 | WO1998006420A1 Bone morphogenetic protein and fibroblast growth factor compositions and methods for the induction of cardiogenesis |
| 02/19/1998 | WO1998006417A1 Methods to treat cerebral ischemic injury and other neuronal diseases |
| 02/19/1998 | WO1998006408A1 Methods and compositions for preventing or retarding the development of atherosclerotic lesions |
| 02/19/1998 | WO1998006401A1 Pharmaceutically active compounds and methods of use |
| 02/19/1998 | WO1998006400A2 Pharmaceutical products for curing and preventing illnesses connected with the malfunction of vascular endothelial cells |
| 02/19/1998 | WO1998006399A1 Il-8 receptor antagonists |
| 02/19/1998 | WO1998006389A1 Intramural delivery of nitric oxide enhancer for inhibiting lesion formation after vascular injury |
| 02/19/1998 | WO1998006262A1 Il-8 receptor antagonists |
| 02/19/1998 | DE19632423A1 Thienopyrimidine Thienopyrimidines |
| 02/19/1998 | CA2263316A1 Methods and compositions for preventing or retarding the development of atherosclerotic lesions |
| 02/19/1998 | CA2263311A1 Cyclic carbamates and isoxazolidines as iib/iiia antagonists |
| 02/19/1998 | CA2263143A1 Keratinocyte growth factor-2 (kgf-2 or fibroblast growth factor-12, fgf-12) |
| 02/19/1998 | CA2263100A1 Pharmaceutically active compounds and methods of use |
| 02/19/1998 | CA2261130A1 Methods to treat cerebral ischemic injury and other neuronal diseases |
| 02/19/1998 | CA2260872A1 Substituted pyrimidine derivatives and their pharmaceutical use |
| 02/18/1998 | EP0823908A1 PYRIDO 2,3-d]PYRIMIDINES FOR INHIBITING PROTEIN TYROSINE KINASE MEDIATED CELLULAR PROLIFERATION |
| 02/18/1998 | EP0823906A1 Piperazino derivatives as neurokinin antagonists |
| 02/18/1998 | EP0823903A1 Heterocyclic diaryl compounds, pharmaceutical and cosmetic compositions containing same, and uses thereof |
| 02/18/1998 | EP0823895A1 Fatty acid esters as bioactive compounds |
| 02/18/1998 | EP0823892A1 Tetralines bearing a phenyl substituant on the aromatic ring and their use in the treatment of epilepsy, stroke and brain or spinal trauma |
| 02/18/1998 | EP0823889A1 1,3-propane diol derivatives as bioactive compounds |
| 02/18/1998 | EP0719252B1 Derivatives of 2-amino-1,2,3,4-tetrahydronaphthalene active on the cardiovascular system |
| 02/18/1998 | CN1173339A 百年乐口服液及其制备方法和应用 Oral century music and its preparation method and application |
| 02/18/1998 | CN1037440C Method for prepn. of angiotensin II receptor blocking 2, 3, 6 substituted quinazolinones |
| 02/17/1998 | US5719303 Phosphonic acid derivatives |
| 02/17/1998 | US5719279 Cholinomimetics |
| 02/17/1998 | US5719278 Tricyclic benzazepine vasopressin antagonists |
| 02/17/1998 | US5719181 Treatment of central nervous system disorders |
| 02/17/1998 | US5719180 Chroman derivatives having vitamin E-like activities |
| 02/17/1998 | US5719175 Protein kinase C inhibitors |
| 02/17/1998 | US5719169 Substituted benzoylguanidines, their use as a medicament or diagnostic, and medicament containing them |
| 02/17/1998 | US5719141 2,9-diamino- and 2-amino-8-carbamoyl-4-hydroxy-alkanoic acid amide derivatives |
| 02/17/1998 | US5719138 Contacting with a dicitrate cyclic diester |
| 02/17/1998 | US5719136 Combination of progesterone antagonists and antiestrogens with partial agonistic action for hormone substitution therapy for perimenopausal and postmenopausal women |
| 02/17/1998 | US5719135 Tyrosine kinase inhibitors |
| 02/17/1998 | US5719127 Modified complement system regulators |
| 02/17/1998 | US5718915 Antiviral liposome having coupled target-binding moiety and hydrolytic enzyme |
| 02/17/1998 | CA1339678C Atrial natriuretic peptide derivative, its production and use thereof for treating gardiac or cerebral circulatory disease |
| 02/12/1998 | WO1998005779A1 Modified tie-2-receptor ligands |
| 02/12/1998 | WO1998005775A1 Gene involved in cadasil, method of diagnosis and therapeutic application |
| 02/12/1998 | WO1998005660A1 Pyrrolo(3,2-c) quinoline derivatives |
| 02/12/1998 | WO1998005648A1 Novel isoquinoline derivatives |
| 02/12/1998 | WO1998005361A2 Long-acting drugs and pharmaceutical compositions comprising them |
| 02/12/1998 | WO1998005353A1 hCG AND DERIVATIVES AS MATRIX METALLOPROTEASES INHIBITORS |
| 02/12/1998 | WO1998005350A1 Materials and methods for treatment of plaquing diseases |
| 02/12/1998 | WO1998005335A1 PURINE INHIBITORS OF CYCLIN DEPENDENT KINASE 2 AND IλB-$g(a) |
| 02/12/1998 | WO1998005333A1 Use of beta-sheet mimetics as protease and kinase inhibitors and as inhibitors of transcription factors |
| 02/12/1998 | WO1998005322A1 Verapamil as a medicament for the treatment of angina |
| 02/12/1998 | WO1998005321A1 Therapeutic utilities of verapamil enantiomers |
| 02/12/1998 | WO1998005317A1 Il-8 receptor antagonists |
| 02/12/1998 | CA2262900A1 Use of beta-sheet mimetics as protease and kinase inhibitors and as inhibitors of transcription factors |
| 02/12/1998 | CA2262459A1 Gene involved in cadasil, method of diagnosis and therapeutic application |
| 02/12/1998 | CA2260786A1 Verapamil as a medicament for the treatment of angina |
| 02/12/1998 | CA2233987A1 Materials and methods for treatment of plaquing diseases |
| 02/11/1998 | EP0823478A2 Human cartilage gp 39-like gene |
| 02/11/1998 | EP0823254A1 Novel use of pyrazolopyridine compounds |
| 02/11/1998 | EP0822983A1 Apopain |
| 02/11/1998 | EP0822936A1 NOVEL SUBSTITUTED TETRAHYDROPYRANO 3,2-d]OXAZOLONES, METHOD FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
| 02/11/1998 | EP0822934A1 Antithrombotic amidinotetrahydropyridylalanine derivatives |
| 02/11/1998 | EP0822826A1 Nitrosylated neuropeptides |
| 02/11/1998 | EP0776323B1 Salts of an anti-migraine indole derivative |
| 02/11/1998 | EP0624164B1 Peptides with organo-protective activity, process for their preparation and their use in the therapy |
| 02/11/1998 | CN1173174A Substituted oxazolidine calpain and/or cathepsin B inhibitors |
| 02/11/1998 | CN1173132A Dihydropyrimidines and uses thereof |
| 02/11/1998 | CN1172803A Bicyclic-fused pyridines |
| 02/10/1998 | US5717102 Psychotherapeutics; headaches |
| 02/10/1998 | US5716989 Bicyclo 3.3.0!octane derivatives, process for their production and their pharmaceutical use |
| 02/10/1998 | US5716979 Tachykinin antagonists |
| 02/10/1998 | US5716975 Nontoxic rhodanine derivatives; antidiabetic agents, cathepsin d inhibitors, b-amyloid protein reduction |
| 02/10/1998 | US5716956 Dihydrophthalazine antagonists of excitatory amino acid receptors |
| 02/10/1998 | US5716955 Cytokine inhibitor |
| 02/10/1998 | US5716945 Antiinflammatory agents; immunostimulation; cell differentiation; antigrowth agents |
| 02/10/1998 | US5716943 Phosphinic acid derivatives with metallopeptidase inhibitory activity |
| 02/10/1998 | US5716595 Intraperative, intravascular and endoscopic tumor and lesion detection and therapy with monovalent antibody fragments |
| 02/10/1998 | CA2079205C Use of hyaluronic acid and forms to prevent arterial restenosis |
| 02/10/1998 | CA1339663C 1-acyl-2,3-dihydro-4(1h)-quinolinone-4-oxime derivate, processfor producingthem and use thereof |
| 02/10/1998 | CA1339661C Cycloalkylamides of (8b)-1alkyl-6 (substituted)ergolines |
| 02/05/1998 | WO1998004714A1 A NOVEL HUMAN mRNA EDITING ENZYME |
| 02/05/1998 | WO1998004521A1 Potassium channel inhibitors |
| 02/05/1998 | WO1998004259A1 ANTITHROMBOTIC AND ANTIATHEROGENIC PHARMACEUTICAL COMPOSITION INCLUDING A THIENOPYRIDINE DERIVATIVE AND AN HMG-CoA-REDUCTASE INHIBITOR |
| 02/05/1998 | WO1998004135A1 Diphenyl heterocycles as potassium channel modulators |
| 02/05/1998 | WO1997047744A3 T-cell selective interleukin-4 agonists |
| 02/05/1998 | CA2261814A1 Potassium channel inhibitors |
| 02/05/1998 | CA2260740A1 A novel human mrna editing enzyme |
| 02/04/1998 | EP0822199A2 N-terminally monopegylated polypeptides and process for their preparation. |
| 02/04/1998 | EP0822186A2 L-tert-leucine-2-pyridylamide |
| 02/04/1998 | EP0822182A1 Substituted indanylidineacetylguanidines as Na+/H+ exchange inhibitors, process for their preparation, their use as medicaments or diagnostic agents and medicaments containing them |
| 02/04/1998 | EP0821968A2 Antihypertensive agent and method for preparing same |
| 02/04/1998 | EP0821960A1 Use of xanthine derivatives for the modulation of apoptosis |
| 02/04/1998 | EP0821952A1 Use of isoxazole and crotonic acid amide derivatives for the modulation of apoptosis |
| 02/04/1998 | EP0821740A1 High efficiency ex vivo transduction of hematopoietic stem cells by recombinant retroviral preparations |
| 02/04/1998 | EP0821728A1 Tie-2 ligands, methods of making and uses thereof |
| 02/04/1998 | EP0821674A1 Cyclic amidino agents useful as nitric oxide synthase inhibitors |